Health systems across the country are making it easier for primary care clinicians to order genetic tests for patients who ...

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc.

Myriad Genetics, Inc. (MYGN), a genetic and genomic tumor testing and precision medicine provider, and INTERLINK Care Management, ...

In a recent study, Mass General Brigham researchers demonstrated that through low-cost genetic samples that can be obtained ...

Ameera Shah-led Metropolis Healthcare Limited, Indias second-largest and most respected pathology laboratory chain, today ...

Mallards over the 30 percent farm-raised DNA threshold are showing poor migration habits The author's drake mallard and three ...

Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted therapies that are more effective and tolerable than traditional ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

A dad who had a DNA test done on his son behind his wife's back has said the results of the test will change the course of ...

A bill is moving through the Wyoming Legislature to give access to post-conviction DNA testing to more Wyoming felons. The ...

The company, founded by 25-year-old Kian Sadeghi, announced a $14 million Series A, bringing its total funding to about $32 million.

Over a year after a dead 15-foot shark was found with mysterious bite wounds and stripped of its internal organs, DNA ...